주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Policy
목록
(
총 :
921 )
기사목록 보기 형태
제목형
요약형
포토형
Korea, China to collaborate on infectious disease management
Lee Han-soo
2024.04.26 16:52
RIGHT Foundation opens grants for global health equity in infectious disease
Lee Han-soo
2024.04.24 16:08
Despite government’s refusal to accept resignation, medical professors ‘quietly’ prepare to leave
Kwak Sung-sun
2024.04.23 16:02
KPBMA head named to chair Korea's healthcare reform panel
Kwak Sung-sun
2024.04.22 11:17
Seoul accepts university heads’ demand to lower medical school enrollment increase target
Kim Yoon-mi
2024.04.19 15:56
Covid-19 crisis to be downgraded to lowest 'attention' level starting in May
Kwak Sung-sun
2024.04.19 15:27
Nurses may benefit from law that lessens penalties for medical accidents
Kwak Sung-sun
2024.04.19 13:08
Keytruda’s coverage expansion effectively ‘shelved’
Kim Yun-mi
2024.04.18 13:55
Controversy erupts over alleged government hurdles for J-1 visas for Korean trainee doctors heading to US hospitals
Kim Ju-yeon
2024.04.18 13:32
'Over 8,000 med students should take classes together, instead of current 3,000'
Kim Eun-young
2024.04.17 15:12
Why does Korea lag behind Japan and Taiwan in long-term management of Covid-19?
Kim Yun-mi
2024.04.17 11:16
Nearly 75% of Korean healthcare service laborers worked 5 years or less
Yang Hyeon-su
2024.04.16 16:58
처음
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기